109 related articles for article (PubMed ID: 17175303)
1. Rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil for C4d-positive acute humoral renal allograft rejection.
Ji SM; Liu ZH; Chen JS; Sha GZ; Ji DX; Li LS
Transplant Proc; 2006 Dec; 38(10):3459-63. PubMed ID: 17175303
[TBL] [Abstract][Full Text] [Related]
2. C4d-positive acute humoral renal allograft rejection: rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil.
Liu M; Ji SM; Tang Zh; Ji DX; Chen HP; Liu ZH; Li LS
Transplant Proc; 2004 Sep; 36(7):2101-3. PubMed ID: 15518760
[TBL] [Abstract][Full Text] [Related]
3. Novel rescue therapy for C4d-positive acute humoral renal allograft rejection.
Min L; Shuming J; Zheng T; Daxi J; Huiping C; Zhihong L; Leishi L
Clin Transplant; 2005 Feb; 19(1):51-5. PubMed ID: 15659134
[TBL] [Abstract][Full Text] [Related]
4. Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil.
Sun Q; Liu ZH; Cheng Z; Chen J; Ji S; Zeng C; Li LS
Kidney Int; 2007 Jan; 71(1):24-30. PubMed ID: 16969384
[TBL] [Abstract][Full Text] [Related]
5. Late developing C4d-positive humoral renal allograft rejection associated with withdrawal of mycophenolate mofetil.
Sun Q; Tang Z; Chen J; Chen H; Liu Z; Li L
Transplant Proc; 2005 Dec; 37(10):4244-5. PubMed ID: 16387089
[TBL] [Abstract][Full Text] [Related]
6. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.
Theruvath TP; Saidman SL; Mauiyyedi S; Delmonico FL; Williams WW; Tolkoff-Rubin N; Collins AB; Colvin RB; Cosimi AB; Pascual M
Transplantation; 2001 Jul; 72(1):77-83. PubMed ID: 11468538
[TBL] [Abstract][Full Text] [Related]
7. Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy.
Schwarz C; Regele H; Huttary N; Wahrmann M; Exner M; Nagy-Bojarsky K; Kletzmayr J; Hörl WH; Böhmig GA
Wien Klin Wochenschr; 2006 Jul; 118(13-14):397-404. PubMed ID: 16865644
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus combined with mycophenolate mofetil can effectively reverse C4d-positive steroid-resistant acute rejection in Chinese renal allograft recipients.
Sun Q; Liu ZH; Yin G; Chen H; Chen J; Ji S; Li LS
Nephrol Dial Transplant; 2006 Feb; 21(2):510-7. PubMed ID: 16421166
[TBL] [Abstract][Full Text] [Related]
9. Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation.
Pascual M; Saidman S; Tolkoff-Rubin N; Williams WW; Mauiyyedi S; Duan JM; Farrell ML; Colvin RB; Cosimi AB; Delmonico FL
Transplantation; 1998 Dec; 66(11):1460-4. PubMed ID: 9869086
[TBL] [Abstract][Full Text] [Related]
10. A case of acute antidonor antibody-mediated humoral rejection after renal transplantation with specific consideration of serial graft biopsy histology.
Shimizu T; Tokiwa M; Yamaguchi Y
Clin Transplant; 2002; 16 Suppl 8():62-7. PubMed ID: 12464135
[TBL] [Abstract][Full Text] [Related]
11. Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics.
Crespo M; Pascual M; Tolkoff-Rubin N; Mauiyyedi S; Collins AB; Fitzpatrick D; Farrell ML; Williams WW; Delmonico FL; Cosimi AB; Colvin RB; Saidman SL
Transplantation; 2001 Mar; 71(5):652-8. PubMed ID: 11292296
[TBL] [Abstract][Full Text] [Related]
12. Early and late humoral rejection: a clinicopathologic entity in two times.
Péfaur J; Díaz P; Panace R; Salinas P; Fiabane A; Quinteros N; Chea R; Naranjo E; Wurgaft A; Beltran E; Elgueta S; Wegmann ME; Gajardo JG; Contreras L
Transplant Proc; 2008 Nov; 40(9):3229-36. PubMed ID: 19010241
[TBL] [Abstract][Full Text] [Related]
13. Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation.
Lederer SR; Friedrich N; Banas B; Welser G; Albert ED; Sitter T
Clin Transplant; 2005 Apr; 19(2):168-74. PubMed ID: 15740551
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of C4d in renal allograft biopsies in different clinical settings: absence of C4d in grafts from non-heart-beating donors.
Crespo M; Sole M; Arostegui JL; Mila J; Martorell J; Oppenheimer F
Transplant Proc; 2005 Nov; 37(9):3688-9. PubMed ID: 16386506
[TBL] [Abstract][Full Text] [Related]
15. The impact of C4d staining as a humoral injury marker.
Kara M; Demir F; Ata P; Ozel L; Gumrukcu G; Unal E; Canbakan M; Gucun M; Esadoglu V; Ozdemir E; Cemel H; Titiz MI
Transplant Proc; 2012; 44(6):1694-6. PubMed ID: 22841245
[TBL] [Abstract][Full Text] [Related]
16. Role of humoral immune reactions as target for antirejection therapy in recipients of a spousal-donor kidney graft.
Böhmig GA; Regele H; Säemann MD; Exner M; Druml W; Kovarik J; Hörl WH; Zlabinger GJ; Watschinger B
Am J Kidney Dis; 2000 Apr; 35(4):667-73. PubMed ID: 10739788
[TBL] [Abstract][Full Text] [Related]
17. C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption.
Böhmig GA; Regele H; Exner M; Derhartunian V; Kletzmayr J; Säemann MD; Hörl WH; Druml W; Watschinger B
J Am Soc Nephrol; 2001 Nov; 12(11):2482-2489. PubMed ID: 11675426
[TBL] [Abstract][Full Text] [Related]
18. Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection.
Boratyńska M; Banasik M; Patrzałek D; Klinger M
Ann Transplant; 2006; 11(2):51-6. PubMed ID: 17494290
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
Gonwa T; Johnson C; Ahsan N; Alfrey EJ; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Leonhardt M; Fitzsimmons WE
Transplantation; 2003 Jun; 75(12):2048-53. PubMed ID: 12829910
[TBL] [Abstract][Full Text] [Related]
20. Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients.
Demirbaş A; Tuncer M; Yavuz A; Gürkan A; Kaçar S; Cetinkaya R; Tekin S; Akbaş SH; Akaydin M; Ersoy F; Yakupoğlu G
Transplant Proc; 2004; 36(1):175-7. PubMed ID: 15013338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
